Trial of Lixisenatide in Early Parkinson’s Disease
2024 · New England Journal of Medicine · 272 citations
https://doi.org/10.1056/nejmoa2312323
M
Mathieu Anheim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
374
Papers
16.0K
Citations
59
h-index
171
i10-index
Mathieu Anheim is an academic researcher from International Space University. The author has contributed to research in topics: Genetic Neurodegenerative Diseases & Mitochondrial Function and Pathology & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 59, co-authored 318 publications.
ORCID: 0000-0001-8121-0605Papers by this author
worksTranslation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome
2017 · Neuron · 235 citations
https://doi.org/10.1016/j.neuron.2016.12.016
Large-scale replication and heterogeneity in Parkinson disease genetic loci
2012 · Neurology · 130 citations
https://doi.org/10.1212/wnl.0b013e318264e353
Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex
2018 · Brain · 111 citations
https://doi.org/10.1093/brain/awy285
The spectrum of functional tic‐like behaviours: Data from an international registry
2022 · European Journal of Neurology · 55 citations
https://doi.org/10.1111/ene.15611
Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions
2023 · EBioMedicine · 52 citations
https://doi.org/10.1016/j.ebiom.2023.104931
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat